相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Toll like receptor 4 in atherosclerosis and plaque destabilization
Wijnand K. den Dekker et al.
ATHEROSCLEROSIS (2010)
Tumor Necrosis Factor Receptor-Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall
Anna Missiou et al.
CIRCULATION (2010)
TRAF5 Deficiency Accelerates Atherogenesis in Mice by Increasing Inflammatory Cell Recruitment and Foam Cell Formation
Anna Missiou et al.
CIRCULATION RESEARCH (2010)
Therapeutic Targeting of Syk in Autoimmune Diabetes
Lucrezia Colonna et al.
JOURNAL OF IMMUNOLOGY (2010)
Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans
Peter Stachon et al.
PLOS ONE (2010)
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Anna Podolanczuk et al.
BLOOD (2009)
Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia
Maike Buchner et al.
CANCER RESEARCH (2009)
Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein Toll-Like Receptor 4-and Spleen Tyrosine Kinase-Dependent Activation of NADPH Oxidase 2
Yun Soo Bae et al.
CIRCULATION RESEARCH (2009)
Protein Tyrosine Kinase, Syk: A Key Player in Phagocytic Cells
Yumi Tohyama et al.
JOURNAL OF BIOCHEMISTRY (2009)
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
Paul M. Ridker
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Absence of p55 TNF Receptor Reduces Atherosclerosis, but Has No Major Effect on Angiotensin II Induced Aneurysms in LDL Receptor Deficient Mice
Sofia Xanthoulea et al.
PLOS ONE (2009)
Treatment of Rheumatoid Arthritis With a Syk Kinase Inhibitor A Twelve-Week, Randomized, Placebo-Controlled Trial
Michael E. Weinblatt et al.
ARTHRITIS AND RHEUMATISM (2008)
Differential Expression and Molecular Associations of Syk in Systemic Lupus Erythematosus T Cells
Sandeep Krishnan et al.
JOURNAL OF IMMUNOLOGY (2008)
DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk
Wei Zou et al.
MOLECULAR CELL (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo
David Frommhold et al.
BMC IMMUNOLOGY (2007)
Syk-Mediated Translocation of PI3Kδ to the Leading Edge Controls Lamellipodium Formation and Migration of Leukocytes
Juergen Schymeinsky et al.
PLOS ONE (2007)
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor
Polly R. Pine et al.
CLINICAL IMMUNOLOGY (2007)
Mouse models for atherosclerosis and pharmaceutical modifiers
Susanne Zadelaar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Expression and mechanism of spleen tyrosine kinase activation by angiotensin II and its implication in protein synthesis in rat vascular smooth muscle cells
Fariborz A. Yaghini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tyrosine kinase Syk associates with toll-like receptor 4 and regulates signaling in human monocytic cells
Anu Chaudhary et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1
Andreas Zirlik et al.
CIRCULATION (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Involvement of Syk protein tyrosine kinase in LPS-induced responses in macrophages
Marina Ulanova et al.
JOURNAL OF ENDOTOXIN RESEARCH (2007)
Spleen tyrosine kinase syk is necessary for E-Selectin-induced alpha(L)beta 2 integrin-mediated rolling on intercellular adhesion molecule-1
Alexander Zarbock et al.
IMMUNITY (2007)
The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for β2 integrin (CD11/CD18)-mediated neutrophil migration
Jurgen Schymeinsky et al.
BLOOD (2006)
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs
Attila Mocsai et al.
NATURE IMMUNOLOGY (2006)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions
Claire Abbal et al.
BLOOD (2006)
T cells in atherogenesis - For better or for worse?
Anna-Karin L. Robertson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease
Filip K. Swirski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation
S Matsubara et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (fractalkine)
JC Gevrey et al.
JOURNAL OF IMMUNOLOGY (2005)
GPVI and integrin αIIβ3 signaling in platelets
SP Watson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
The non-receptor tyrosine kinase Syk regulates lamellipodium formation and site-directed migration of human leukocytes
P Schymeinsky et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-κB activation, and apoptosis
Y Takada et al.
JOURNAL OF IMMUNOLOGY (2004)
Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
U Schönbeck et al.
CIRCULATION (2004)
A role for Syk-kinase in the control of the binding cycle of the β2 integrins (CD11/CD18) in human polymorphonuclear neutrophils
T Willeke et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation
C Sedlik et al.
JOURNAL OF IMMUNOLOGY (2003)
Syk is required for integrin signaling in neutrophils
A Mócsai et al.
IMMUNITY (2002)
Syk expression and novel function in a wide variety of tissues
S Yanagi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
A critical role for Syk in endothelial cell proliferation and migration
R Inatome et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Structure and function of Syk protein-tyrosine kinase
K Sada et al.
JOURNAL OF BIOCHEMISTRY (2001)